TP53 and neoplasm: In a study done by Feng et al. [101] vIAP was shown to promote IκB and p53 tumor suppressor degradation via interaction with cellular PLIC1/ubiquilin, thus releasing inactive NF-kB, which promotes chronic inflammation.